Betagenon is a clinical stage company that develops MPK activators as novel innovative treatments for major diseases.
Employees: 11-50
Investors 1
| Date | Name | Website |
| - | BioVenture... | azbioventu... |
Mentions in press and media 10
| Date | Title | Description |
| 23.12.2021 | Betagenon co-founder publishes that AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced obese mice | Betagenon co-founder publishes that AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced obese mice Thu, Dec 23, 2021 14:35 CET Betagenon AB, a Sweden-based company focused on de... |
| 23.12.2021 | Betagenon co-founder publishes that AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced obese mice | STOCKHOLM, Dec. 23, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced the publication by co-founder Helena Edlund of a new study demonstrating the prevention and re... |
| 18.11.2021 | Betagenon co-founder publishes study demonstrating that pan-AMPK activator O304 acts as an exercise mimetic in aged mice | Betagenon co-founder publishes study demonstrating that pan-AMPK activator O304 acts as an exercise mimetic in aged mice Thu, Nov 18, 2021 13:40 CET Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, to... |
| 18.11.2021 | Betagenon co-founder publishes study demonstrating that pan-AMPK activator O304 acts as an exercise mimetic in aged mice | STOCKHOLM, Nov. 18, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced the publication by co-founder Prof. Helena Edlund of a new study demonstrating that in aged mi... |
| 02.06.2021 | Betagenon AB announces investment and collaboration with Hong Kong-based MCG Technology Group Ltd | STOCKHOLM, June 2, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based biotech company focused on development of AMPK activator compounds, and MCG Technology Group Ltd, a Hong Kong-based biotech investment group, today announced that MCG Tech... |
| 02.06.2021 | Betagenon AB announces investment and collaboration with Hong Kong-based MCG Technology Group Ltd | Betagenon AB announces investment and collaboration with Hong Kong-based MCG Technology Group Ltd Wed, Jun 02, 2021 08:35 CET Betagenon AB, a Sweden-based biotech company focused on development of AMPK activator compounds, and MCG Technolog... |
| 02.06.2021 | Betagenon AB : announces investment and collaboration with Hong Kong-based MCG Technology Group Ltd | STOCKHOLM, June 2, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based biotech company focused on development of AMPK activator compounds, and MCG Technology Group Ltd, a Hong Kong-based biotech investment group, today announced that MCG Tech... |
| 27.05.2021 | Betagenon AB announces new CEO and new Chairman of the Board | STOCKHOLM, May 27, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced that James Hall BM, BCh, D.Phil has joined this month as CEO. Dr. Hall brings extensive senior ... |
| 27.05.2021 | Betagenon AB announces new CEO and new Chairman of the Board | Betagenon AB announces new CEO and new Chairman of the Board Thu, May 27, 2021 09:05 CET Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced that James Hall BM, BCh, D.Phil has joined thi... |
| 27.05.2021 | Betagenon AB : announces new CEO and new Chairman of the Board | STOCKHOLM, May 27, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced that James Hall BM, BCh, D.Phil has joined this month as CEO. Dr. Hall brings extensive senior ... |